<DOC>
	<DOCNO>NCT00003678</DOCNO>
	<brief_summary>RATIONALE : Estrogen stimulate growth breast cancer cell . Hormone therapy use tamoxifen may fight breast cancer block uptake estrogen tumor cell . PURPOSE : Randomized phase III trial compare effectiveness least 2 year tamoxifen 5 additional year tamoxifen treat woman breast cancer surgically remove .</brief_summary>
	<brief_title>Tamoxifen Treating Women With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare disease-free overall survival woman early breast cancer randomize discontinue adjuvant tamoxifen v randomize continue least 5 additional year . OUTLINE : This randomize study . Patients stratify analysis accord duration tamoxifen give randomization ( 2-3 year v 4-5 year v 6-7 year v 8-9 year vs 10 year ) , age ( le 49 v 50 ) , important prognostic factor , include tumor type grade nodal estrogen receptor status . Patients randomize 1 2 treatment arm . - Arm I : Patients discontinue tamoxifen least 2 year prior treatment . - Arm II : Patients continue treatment tamoxifen least 5 additional year absence unacceptable toxicity disease progression . Patients follow annually . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 8,000-20,000 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast carcinoma completely excise Clinically relapse free Must complete least two year adjuvant therapy tamoxifen early breast cancer AND clear indication receive tamoxifen No significant endometrial hyperplasia No patient negligibly low risk breast cancer death Hormone receptor status : Any status allow PATIENT CHARACTERISTICS : Age : Not specify Sex : Female Menopausal status : Any status allow Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No life threaten disease No retinopathy No psychiatric disorder condition would preclude study compliance No serious toxicity ( e.g. , depression ) think due tamoxifen Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : See Disease Characteristics Radiotherapy : Not specify Surgery : See Disease Characteristics Other : Any primary treatment allow</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>